The COVID-19 pandemic has disrupted our lives. Medical experts around the globe have said that what we each have known as normal life won’t fully resume until we have a vaccine, and that could take years. In this webinar, an expert panel will take you inside the race to develop a COVID-19 vaccine. What’s involved in developing a vaccine? Why does it take so long? What pathways are being explored? What clinical trials are under way and when will they be completed? Once we have a vaccine, what’s involved in adding it to Canada’s national immunization program?
Speakers:
- Megan Bettle, PhD, Director, Centre for Regulatory Excellence, Statistics and Trials, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada
- Monika Naus, MD, FRCPC, Medical Director, Communicable Diseases & Immunization Service; Medical Head, Immunization Programs & Vaccine Preventable Diseases, BC Centre for Disease Control
- Dion Neame, MD, BCh, BSc, FRCPC, FAAP, Country Medical Lead, Country Medical Head – Vaccines, Sanofi Canada
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.